For biotech companies, the healthcare sector and media.

We are proud to present a new partnership with OptiCell Solutions.
Today OptiCell Solutions, that is improving access to target cells for cell and gene therapies, released its first press release.

As demand for advanced precision medical treatments increases, OptiCell Solutions, an innovative actor, introduces cutting-edge solutions to meet the critical needs within the healthcare and the pharmaceutical industry. The company specializes in the collection and delivery of high-quality cell collections and the performance of therapeutic apheresis treatments, two areas where there is a significant lack of resources. “We often struggle to get healthcare to collect cells from our donors”, says Mats Bengtsson, medical director at the Tobias Registry.

CliniQnect and OptiCell Solutions work together to integrate cutting-edge cell collection with decentralized clinical trial and patient support, improving accessibility and quality of care.

➡ Read the full press release on OptiCell’s website, https://opticellsolutions.com/improving-access-to-target-cells/